Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. [electronic resource]
Producer: 20090924Description: 1615-1623.e1 p. digitalISSN:- 1549-4713
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Aza Compounds -- administration & dosage
- Azepines -- administration & dosage
- Child
- Child, Preschool
- Conjunctiva -- microbiology
- Conjunctivitis, Bacterial -- drug therapy
- Double-Blind Method
- Female
- Fluoroquinolones -- administration & dosage
- Haemophilus influenzae -- isolation & purification
- Humans
- Infant
- Male
- Microscopy, Acoustic
- Middle Aged
- Moxifloxacin
- Ophthalmic Solutions -- administration & dosage
- Quinolines -- administration & dosage
- Staphylococcus aureus -- isolation & purification
- Staphylococcus epidermidis -- isolation & purification
- Streptococcus pneumoniae -- isolation & purification
- Treatment Outcome
- Visual Acuity
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.